Skip to main content
INGN
NASDAQ Life Sciences

Inogen Swaps CEO, Elevates COO Andy Reding as Kevin Smith Departs

Tom Rudovsky · Reported by BusinessWire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$6.805
Mkt Cap
$180.593M
52W Low
$5.045
52W High
$8.14
52W Position info
35% above low
Off High info
16% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

INGN sits 35% above its 52-week low of $5.045.

Summary

Inogen's board named COO Andy Reding as President and CEO and put him on the board, replacing Kevin Smith. Reding only joined the company as COO in July 2026, so this is a rapid promotion of a newcomer rather than a long-tenured internal handoff. Board chair Elizabeth Mora framed the move bluntly: the company has an opportunity but "must do more to improve performance," and the board decided now was the right time for a change. Reding was central to the Rotech divestiture announced September 30, which the company expects to push it toward a leaner commercial model. The timing matters — the same release says Q3 2026 results come out today with a 5:00 p.m. ET call, so the new CEO inherits the numbers and the guidance discussion immediately.

At the time of this announcement, INGN was trading at $6.81 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $180.6M. The 52-week trading range was $5.05 to $8.14. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

INGN - Latest Insights

INGN
Nov 05, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.30
Real-time Price: $5.66 info
Change: -$0.6399 (-10%) info
Market Cap: $179.665M info
INGN
Nov 05, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $6.50
Real-time Price: $5.66 info
Change: -$0.840 (-13%) info
Market Cap: $179.665M info
INGN
Sep 30, 2026, 5:26 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $5.62
Real-time Price: $5.66 info
Change: +$0.040 (+0.71%) info
Market Cap: $179.665M info
INGN
Sep 30, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.27
Real-time Price: $5.66 info
Change: +$0.390 (+7%) info
Market Cap: $179.665M info
INGN
Aug 07, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $6.05
Real-time Price: $5.66 info
Change: -$0.390 (-6%) info
Market Cap: $179.665M info